CAPLIPOINT - Caplin Point Laboratories

Caplin Point Laboratories

CAPLIPOINT · Pharma > Pharmaceuticals & Drugs · Chairman: C C Paarthipan · MD: Sridhar Ganesan · Listing date: June 23, 2014 · Employees: 1675 · Chennai · http://www.caplinpoint.net

Stock Price vs Company Growth

2.4%

3.8%

1.3%

7.2%

23.8%

92.5%

30.6%

all

44.6%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,299 2.4%

1,240

1,618

Company Overview

Sales

1,630 Cr

Growth: 14.0%

Profit after Tax

438 Cr

Growth: 4.7%

Mid Cap

9,863 Cr

P/E: 22.7x

Industry P/E: 35.0x

Fundamentals

Sales (Cr)	₹ 1,630
Growth	14.0%
EBITDA	32.5%
P/S	6.1x
Dividend	0.5%
P/E	22.7x
Book Value	₹ 292
PEG Ratio	1.6x
ROE	21.4%
P/B	4.5x

Shareholding Pattern

Institutions

Promoters

P Vijayalakhsmi

23.64 %

Paarthipan C C

18.73 %

Ashok Gorkey Partheeban

11.96 %

Partheeban Vivek Siddarth

11.9 %

May India Property Private Limited

2.8 %

Others

Iepf

2.46 %

Visalatchi

2.22 %

Suresh Kumar Agarwal

1.32 %

Ashish Kacholia

1.16 %

Llp

0.7 %

Increase Decrease No change

Company Profile Detailed

Caplin Point is the mid-sized company in India’s pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility.

Belongs to (12 Indices) view more

Investors (51)

iepf

liabilit...

vikramjo...

Followers (27)

rohit66

damerla

bhaskar2